Tvardi Therapeutics Inc (TVRD) Hedge Fund Ownership (Q2 2026)

Q: Is it too late to buy Tvardi Therapeutics Inc (TVRD) following the 2026 Q2 hedge fund 13F filings?

As of today, TVRD has moved -15.3% since the 2026 Q2 13F filing date (August 14, 2026), compared to +1.4% for the XLV sector ETF — an outperformance of -16.7%. Since the quarter end (June 30, 2026), TVRD gained -15.3% vs +6.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Tvardi Therapeutics Inc (TVRD)

58 + Investors. Track Smart Money conviction in TVRD. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — TVRD

Based on 58 hedge funds · latest filing: 2026 Q2 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q

For 1 consecutive quarter, more hedge funds reduced or closed their TVRD positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

📊

High ownership — 89% of 3.0Y peak

89% of all-time peak

58 funds currently hold this stock — 89% of the 3.0-year high of 65 funds (reached 2026 Q1). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.

🚀

Fast accumulation — +26% more funds vs a year ago

fund count last 6Q

+12 new funds entered over the past year (+26% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🔴

Heavy selling pressure — only 34% buying

23 buying45 selling

Last quarter: 45 funds sold vs only 23 buyers. This is widespread institutional distribution — not a few funds rebalancing, but a broad exit. High conviction bearish signal.

➡️

Steady new buyers — ~16 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 25 → 17 → 16 → 16. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔄

Mostly new holders — 50% entered in last year

■ 3% conviction (2yr+) ■ 47% medium ■ 50% new

Only 2 funds (3%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💎

Buying through price weakness — shares -18%, value -51%

Value

-51%

-17%

Last quarter: funds added -18% more shares while total portfolio value only changed -51%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

📊

Peak discovery — momentum slowing

46 → 25 → 17 → 16 → 16 new funds/Q

New funds entering each quarter: 25 → 17 → 16 → 16. TVRD is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.

🌱

Early stage — 97% of holders entered in last year

■ 3% veterans ■ 0% 1-2yr ■ 97% new

Of 58 current holders: 56 (97%) entered in the past year, only 2 (3%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

✅

Strong quality — 23% AUM from major funds

23% from top-100 AUM funds

17 of 58 holders rank in the top 100 by AUM, accounting for 23% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

4.6

out of 10

Moderate Exit Risk

Exit risk score 4.6/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	58	65	-10.77%
13F Shares	2M	3M	-17.53%
Total Value	$4M	$9M	-50.98%
New Positions	16	16	-
Increased Positions	7	18	-11
Closed Positions	23	15	+8
Reduced Positions	22	16	+6
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

-10.77%

13F Shares

-17.53%

Total Value

$4M

$9M

-50.98%

New Positions

Increased Positions

-11

Closed Positions

Reduced Positions

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

58 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TVRD. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 TVRD holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	American Financial Group Inc	0.15%	223,659	$425K
2	Duncan Williams Asset Management, LLC	0.03%	63,241	$120K
3	Slate Path Capital LP	0.02%	704,118	$1.3M
4	Diadema Partners LP	0.00%	16,607	$32K
5	Persistent Asset Partners Ltd	0.00%	4,253	$8K
6	Silvercrest Asset Management Group LLC	0.00%	101,034	$192K
7	XTX Topco Ltd	0.00%	14,868	$28K
8	Renaissance Technologies LLC	0.00%	91,409	$174K
9	Tower Research Capital LLC (TRC)	0.00%	3,275	$6K
10	Savant Capital, LLC	0.00%	19,462	$49K
11	Arax Advisory Partners	0.00%	11,003	$21K
12	Russell Investments Group, Ltd.	0.00%	43,228	$82K
13	Brown Advisory Inc	0.00%	11,200	$21K
14	UBS Group AG	0.00%	111,133	$211K
15	Vanguard Fiduciary Trust Co	0.00%	44,710	$85K
16	Qube Research & Technologies Ltd	0.00%	10,210	$19K
17	Aqr Capital Management LLC	0.00%	27,096	$51K
18	Vanguard Capital Management LLC	0.00%	344,382	$654K
19	Morgan Stanley	0.00%	77,845	$148K
20	TD Private Client Wealth LLC	0.00%	149	—
21	Susquehanna International Group, LLP	0.00%	33,165	$63K
22	LRI Investments, LLC	0.00%	27	—
23	PNC Financial Services Group, INC.	0.00%	3,518	$7K
24	EverSource Wealth Advisors, LLC	0.00%	46	—
25	GAMMA Investing LLC	0.00%	40	—

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Tvardi Therapeutics Inc (TVRD)

What does the Smart Money Trend signal show for TVRD?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their TVRD positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for TVRD?

Heavy selling pressure — only 34% buying: Last quarter: 45 funds sold vs only 23 buyers. This is widespread institutional distribution — not a few funds rebalancing, but a broad exit. High conviction bearish signal.

What is the fund quality score for TVRD holders?

Strong quality — 23% AUM from major funds: 17 of 58 holders rank in the top 100 by AUM, accounting for 23% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held TVRD?

Mostly new holders — 50% entered in last year: Only 2 funds (3%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Tvardi Therapeutics Inc (TVRD) following the 2026 Q2 hedge fund 13F filings?

As of today, TVRD has moved -15.3% since the 2026 Q2 13F filing date (August 14, 2026), compared to +1.4% for the XLV sector ETF — an outperformance of -16.7%. Since the quarter end (June 30, 2026), TVRD has gained -15.3% vs +6.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Tvardi Therapeutics Inc (TVRD)

Smart Money Signals — TVRD

Selling streak — 1 quarter in a row

High ownership — 89% of 3.0Y peak

Fast accumulation — +26% more funds vs a year ago

Heavy selling pressure — only 34% buying

Steady new buyers — ~16 new funds per quarter

Mostly new holders — 50% entered in last year

Buying through price weakness — shares -18%, value -51%

Peak discovery — momentum slowing

Early stage — 97% of holders entered in last year

Strong quality — 23% AUM from major funds

Institutional Sentiment Summary — TVRD

Hedge Fund Ownership: TVRD

Market Analysis: TVRD

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: TVRD

Is It Too Late to Buy Tvardi Therapeutics Inc (TVRD) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: TVRD

Statistics: TVRD

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Tvardi Therapeutics Inc (TVRD)

Welcome to 13Foresight!